ARCA biopharma approves 1-for-12 reverse stock split
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Aug 23 2024
0mins
Source: SeekingAlpha
Reverse Stock Split Announcement: ARCA biopharma has approved a 1-for-12 reverse stock split, reducing its shares from approximately 14.5 million to about 1.2 million, effective September 3, 2024.
Company Name and Symbol Change: Following the merger with Oruka, ARCA will change its name to Oruka Therapeutics and its trading symbol to "ORKA" on the Nasdaq Global Market.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
